Russian Billionaire Dumps Apple, Facebook for Alibaba
Russian billionaire Alisher Usmanov reportedly has sold shares in Apple and Facebook to focus on Alibaba and other tech investments in China. He also may expand his stakes in Russian assets.
Russian billionaire Alisher Usmanov reportedly has sold shares in Apple and Facebook to focus on Alibaba and other tech investments in China. He also may expand his stakes in Russian assets.
News that Hertz Global Holdings will spin off its construction equipment rental business pleased investors, who pushed shares sharply higher after the opening bell Monday. Details of the deal could be announced this week.
courtesy of Apple Inc.iPhone 6 users may be able to get weather reports from their phones — not by asking Siri to check with external sources, but from temperature, humidity and pressure sensors built…
The Los Angeles Times reported over the weekend that the city of Los Angeles has filed a lawsuit against Time Warner Cable for allegedly cheating on its franchise fees to the city for more…
While CEO Mark Zuckerberg has been offering the president his two cents on government spying, Facebook announced Thursday that it has begun to roll out "premium" video ads in the feeds of its users.
In a new research report, the boutique firm Leerink highlights 10 top biotech names that are strong candidates for a partnership or acquisition. Any of these picks may be a great addition for portfolios…
In a new report out from Jefferies, the analysts posted a complete list of the cheapest, on a P/E basis, of the top health care stocks to buy now. Investors concerned about the toppy…
The Keurig brand was just recognized as the "Brand of the Year" in its category in the 2014 Harris Poll EquiTrend Equity Study, for the third year in a row. The company recently changed…
ThinkstockThe outlook for a long-sought federal fix of state sales taxation of online retailers looks dim after comments Wednesday by Robert Goodlatte, chairman of the U.S. House of Representatives Judiciary Committee, suggested the House…
ThinkstockWhile the slow grind higher in big carrier network spending has not led to a capital expenditure explosion, the continued capacity and latency build out of the Internet has some companies’ growth starting to…
In a new research report from Deutsche Bank, the equity strategists point that the companies that are maintaining and increasing share buybacks, plus maintaining and increasing dividends, are the stocks to buy now.
The chief strategist at Piper Jaffray released his report for March. It details how the second and third quarters typically behave in the mid-term years after a solid first quarter. Here are the top…
ThinkstockRecent bad weather, a surge in crude shipments and a record grain crop have combined to create a jam in cargo delivered by rail. Train speeds have dropped around 9% in past few months,…
SolarCity and Best Buy have teamed up to help customers go solar. The aim for the solar panel installer is to get face time with shoppers to explain how much money they could save.…
Despite there being a good possibility that GM will not face any legal liability for the 13 deaths caused by an ignition defect in 1.4 million cars built between 2003 and 2007, that will…
While J.C. Penney has taken some positive steps toward a turnaround, the retail analysts at Sterne Agee are advising their clients that chasing this name is not a good idea.
The pricier the stock market gets, the more important it is for investors to keep a close eye on what they are paying for stocks. Flashy momentum stocks are great for traders, but investors…
Vornado Realty Trust apparently is looking for any avenue it can to generate more value for its shareholders. The New York-based commercial landlord reportedly is considering a spin-off of its suburban shopping centers as…
ThinkstockWednesday, the makers of the popular smartphone game Candy Crush Saga filed for an initial public offering. Dublin-based King Digital Entertainment plans to offer more than 22 million shares, priced at $21 to $24…
Biotech and emerging pharmaceutical stocks continue to be hot, but short sellers shied away from many of them in late February. Those bucking that trend include BioMarin Pharmaceutical and Medivation.